Childhood nail psoriasis: A useful treatment with tazarotene 0.05%

Laura Diluvio, Elena Campione, Evelin J. Paternò, Cristina Mordenti, Maya El Hachem, Sergio Chimenti

Research output: Contribution to journalArticle


Nail psoriasis occurs in 7% to 40% of children, with a similar pattern of clinical presentation to that of adults. In 0.6% to 2.3% of the patients nail changes appear as the only sign of the disease, preceding other skin and articular involvement. No pediatric clinical trials are available yet, but considering the successful use of tazarotene for nail dystrophy therapy in adults, we chose this drug to treat a child.

Original languageEnglish
Pages (from-to)332-333
Number of pages2
JournalPediatric Dermatology
Issue number3
Publication statusPublished - May 2007


ASJC Scopus subject areas

  • Dermatology
  • Pediatrics, Perinatology, and Child Health

Cite this

Diluvio, L., Campione, E., Paternò, E. J., Mordenti, C., Hachem, M. E., & Chimenti, S. (2007). Childhood nail psoriasis: A useful treatment with tazarotene 0.05%. Pediatric Dermatology, 24(3), 332-333.